Abivax
Luc Teyton is a Professor at the Department of Immunology and Microbiology, Scripps Research Center, California Campus, U.S.
This person is not in the org chart
This person is not in any offices
Abivax
Abivax SA is a clinical-stage, publicly traded biotechnology company harnessing the immune system to develop novel treatments against inflammatory diseases, viral diseases and cancer.